Stockscreener 앱 받기
40.65
1.37%
0.55
전일 마감가:
$40.10
열려 있는:
$40.14
하루 거래량:
779.66K
Relative Volume:
2.25
시가총액:
$1.93B
수익:
$405.04M
순이익/손실:
$-17.90M
주가수익비율:
-94.60
EPS:
-0.4297
순현금흐름:
$7.66M
1주 성능:
+3.02%
1개월 성능:
-5.22%
6개월 성능:
-7.30%
1년 성능:
+36.18%
1일 변동 폭
$39.55
$40.93
1주일 범위
$39.08
$41.00
52주 변동 폭
$21.97
$48.25
Artivion Inc Stock (AORT) Company Profile
명칭
Artivion Inc
전화
(770) 419-3355
주소
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
40.65 | 1.90B | 405.04M | -17.90M | 7.66M | -0.4297 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-13 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | 개시 | Canaccord Genuity | Buy |
| 2024-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-27 | 재확인 | Lake Street | Buy |
| 2022-08-08 | 개시 | Lake Street | Buy |
| 2022-03-03 | 개시 | Stifel | Buy |
모두보기
Artivion Inc 주식(AORT)의 최신 뉴스
Artivion Inc (AORT) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Artivion Q4 Earnings Call Highlights - Yahoo Finance
Artivion Q4 2025 slides: double-digit growth across product lines, strong 2026 outlook By Investing.com - Investing.com South Africa
Artivion (AORT) Q4 2025 Earnings Call Transcript - The Globe and Mail
Artivion Q4 2025 slides: double-digit growth across product lines, strong 2026 outlook - Investing.com India
Earnings call transcript: Artivion Q4 2025 beats EPS forecast, stock rises - Investing.com
Artivion (NYSE:AORT) Misses Q4 CY2025 Sales Expectations - Finviz
Artivion (AORT) Q4 Earnings Surpass Estimates - Yahoo Finance UK
Artivion: Fourth Quarter Financial Highlights - Bitget
Artivion: Q4 Earnings Snapshot | State | mdjonline.com - Marietta Daily Journal
Artivion: Q4 Earnings Snapshot - kare11.com
Artivion (NYSE:AORT) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Earnings Flash (AORT) Artivion, Inc. Reports Q4 Revenue $116.0M, vs. FactSet Est of $116.5M - marketscreener.com
Artivion shares fall as Q4 revenue misses analyst estimates By Investing.com - Investing.com Australia
Artivion shares fall as Q4 revenue misses analyst estimates - Investing.com
Artivion Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire
MACD Signal: Will Artivion Inc stock go up in YEARWatch List & Low Drawdown Momentum Ideas - baoquankhu1.vn
Artivion earnings on deck: Can revenue growth offset profit concerns? By Investing.com - Investing.com Nigeria
Artivion earnings on deck: Can revenue growth offset profit concerns? - Investing.com
Artivion Becomes Oversold (AORT) - Nasdaq
Aug Wrap: Is Artivion Inc stock undervalued right nowSwing Trade & Real-Time Buy Zone Alerts - baoquankhu1.vn
What To Expect From Artivion's (AORT) Q4 Earnings - Finviz
What To Expect From Artivion’s (AORT) Q4 Earnings - TradingView
Is PDF Solutions Inc subject to activist investor interest2025 Earnings Impact & Short-Term Swing Trade Alerts - baoquankhu1.vn
Market Recap: Is Artivion Inc stock undervalued right now2025 Technical Patterns & Technical Pattern Alert System - baoquankhu1.vn
Artivion, Inc. (NYSE:AORT) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
US Market Recap: Whats the beta of Artivion Inc stockTake Profit & AI Driven Stock Price Forecasts - baoquankhu1.vn
Artivion (AORT) to Release Earnings on Thursday - Defense World
Earnings Miss: Is Artivion Inc a momentum stockJuly 2025 Short Interest & AI Driven Price Predictions - baoquankhu1.vn
Aug Outlook: What is the long term forecast for Artivion Inc stock2025 Fundamental Recap & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Sell Signal: Is Artivion Inc being accumulated by smart moneyJuly 2025 Momentum & Low Risk Growth Stock Ideas - baoquankhu1.vn
Artivion, Inc. (AORT) Investor Outlook: Potential Upside Of 25.43% And Strong Buy Ratings - DirectorsTalk Interviews
Artivion reports positive clinical data from aortic arch trials By Investing.com - Investing.com Nigeria
The Analyst Verdict: Artivion In The Eyes Of 4 Experts - Benzinga
Needham Reiterates Buy Rating for Artivion (AORT) with $58 Targe - GuruFocus
Artivion (NYSE:AORT) Receives Buy Rating from Needham & Company LLC - MarketBeat
Artivion, Inc. Announces Presentation of Positive New Clinical Data from Endospan's Nexus Trial and its Amds PERSEVERE IDE Trial - marketscreener.com
Artivion (AORT) Unveils Promising Clinical Data from Key Trials - GuruFocus
Artivion reports positive clinical data from aortic arch trials - Investing.com
Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting - PR Newswire
Artivion (AORT) Valuation Check After Recent Share Price Moves And Growth Outlook - Yahoo Finance UK
Market Outlook: Whats next for Artivion Inc stockWeekly Trade Analysis & Low Risk Investment Opportunities - baoquankhu1.vn
What is the long term forecast for Artivion Inc. stockWeekly Profit Summary & Free Community Consensus Stock Picks - mfd.ru
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results - ChartMill
Aug Sentiment: Is Artivion Inc a momentum stockJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - baoquankhu1.vn
Aug Decliners: Is Artivion Inc stock undervalued right now2025 Market Outlook & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Artivion (NYSE:AORT) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
Artivion, Inc. (AORT) Stock Analysis: Unlocking a Potential 19% Upside in the Medical Devices Sector - DirectorsTalk Interviews
Are Options Traders Betting on a Big Move in Artivion Stock? - MSN
Relative Strength Alert For Artivion - Nasdaq
Artivion, Inc. (AORT) Stock Analysis: 20% Upside Potential and a Strong Buy Consensus Signal Opportunity for Investors - DirectorsTalk Interviews
Artivion Inc (AORT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
0.31%
자본화:
|
볼륨(24시간):